TECLens has commenced the first-in-human clinical trial assessing its quantitative corneal crosslinking (qCXL) technology for non-invasive refractive vision correction, administering treatment to the initial...
VESTECK announced that implanting clinicians will present two-year follow-up data from the company’s first-in-human experience with the SUTURE-TIGHT™ Endovascular Catheter System, an adjunctive fixation...
Kandu Health announced positive results from the first randomized controlled trial of its brain-computer interface (BCI) therapy.
The trial evaluated its FDA-cleared, non-invasive IpsiHand BCI...
CorTec GmbH, a pioneer in active implantable medical technologies, announced the successful second implantation of its proprietary BrainComputer Interface (BCI) system, the Brain Interchange,...
Atraverse Medical announced new clinical and preclinical data supporting its Hotwire transseptal access system. Hotwire is a novel radiofrequency guidewire left-heart access device. It...
Artivion has debuted long-term clinical data on two of its cardiac stent products, revealing each’s solution’s potential to offer extended benefits to patients.
This includes...
Biotronik announced the successful first-in-human implantations of its LivIQ leadless pacemaker system.
The implants came in Australia as part of the company’s BIO|CONCEPT.LivIQ study, a...
Robocath announced that it launched a first-in-human clinical study evaluating its new robotic system in coronary artery disease.
The Rouen, France-based company said its second-generation...
ReGelTec Inc., a company developing a percutaneous hydrogel implant for the treatment of chronic low back pain caused by degenerative disc disease, announced the...